B+
Bull case
25%
Probability
Target price
$205.00
Analysis reference price unavailable
Analysis 2026-10-28 · RankAlpha Sentiment Codex
UHS
Universal Health ServicesBNYSE / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
Revenue growth, hospital volume and 2026 guidance reaffirmation could support a recovery if margins stabilize. The packet's $195.125 mean target implies about 10% upside from the $177.32 anchor, but its analyst count and currency of revisions are unknown.
Posture
Constructive
Lead driver
Value
What changed
1 setup hits (3d) with net bearish as of 2026-10-29.
What can break
A tentative litigation settlement drove a $26 million Q3 liability-reserve increase; supplemental Medicaid payments supplied a partly offsetting $47 million benefit. [#SEC-8K-2026-10-27]
Momentum
55
Value
70
Sentiment
52
Setup hits (3d)
1 · Net Bearish
AI TargetsBase $177.00 · Bull $205.00 · Bear $150.00Analysis 2026-10-28; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-29 • Vendor: Data Vendor v1
Scores
As of 2026-10-29 • Model: HYBRID_IC_RP
AI Memo
As of 2026-10-28 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-29
Investment thesis
As of 2026-10-29
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-29. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Bearish
Target $191.19
Why
Momentum55 · Δ7d -28.2
Value70 · Δ7d +0.4
Sentiment52 · Δ7d +11.2
So what
Strength-led posture (Net Bearish). Favor watchlist adds and disciplined entries.
Confirming evidence
- • 1 setup hits (3d) with net bearish as of 2026-10-29.
- • Value remains the lead driver in the composite, 7D delta +0.4.
Contradictions & invalidation
- • A tentative litigation settlement drove a $26 million Q3 liability-reserve increase; supplemental Medicaid payments supplied a partly offsetting $47 million benefit. [#SEC-8K-2026-10-27]
- • Acute-care and behavioral-health EBITDA margins fell 120 and 260 basis points year over year, respectively. UHS Q3 supplemental disclosures
- • Adjusted EBITDA declined despite revenue growth, both operating segments lost margin, and management expects full-year EBITDA toward the low end of its range.
Catalyst clock
2026-10-28
Q3 earnings: revenue growth, weaker profit
Lead driver: Value · See fundamentals
Momentum
55
8% active weight
Current posture
7d trendSoftening
Δ7d
-28.2
Δ21d
-20.1
Value
70
47% active weight
Current posture
7d trendFlat
Δ7d
+0.4
Δ21d
+0.2
Sentiment
52
45% active weight
Current posture
7d trendImproving
Δ7d
+11.2
Δ21d
+2.4
Why this grade
Composite grade B. Momentum 54.8 / Value 70.3 / Sentiment 52.4
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-10-28. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$177.00
Analysis reference price unavailable
Analysis 2026-10-28 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$150.00
Analysis reference price unavailable
Analysis 2026-10-28 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-29
Fundamentals (TTM)
As of 2026-10-29
Market Cap
$10.41B
Beta
1.27
Shares Out
58.94M
P/E (TTM)
10.6
P/S (TTM)
0.82
P/FCF (TTM)
15.20
Rev YoY
+8.3%
EPS YoY
+10.1%
Gross Margin
+11.4%
Op Margin
+11.4%
Net Debt
$5.03B
Current Ratio
1.12
As of 2026-10-29 • Updated nightlySource: Internal modelMethods & Data